机构:[1]Department of Neurology,Xuanwu Hospital, Capital Medical University,Beijing,China.神经科系统神经内科首都医科大学宣武医院[2]Department of Neuroimmunology,Henan Institute of Medical and Pharmaceutical Sciences,Zhengzhou University,Zhengzhou,China.[3]Department of Neurology,Huashan Hospital and Institute of Neurology,Fudan University,Shanghai, China.
第一作者机构:[1]Department of Neurology,Xuanwu Hospital, Capital Medical University,Beijing,China.[*1]Department of Neurology, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China
通讯作者:
通讯机构:[1]Department of Neurology,Xuanwu Hospital, Capital Medical University,Beijing,China.[*1]Department of Neurology, Xuanwu Hospital, Capital Medical University, 45 Changchun Street, Beijing, 100053, China
推荐引用方式(GB/T 7714):
Li Hai-Feng,Gao Feng,Chen Xiang-Jun.Autoantibody levels as biomarkers of disease activity in management of myasthenia gravis[J].EUROPEAN JOURNAL OF NEUROLOGY.2023,30(4):1160-1161.doi:10.1111/ene.15687.
APA:
Li Hai-Feng,Gao Feng&Chen Xiang-Jun.(2023).Autoantibody levels as biomarkers of disease activity in management of myasthenia gravis.EUROPEAN JOURNAL OF NEUROLOGY,30,(4)
MLA:
Li Hai-Feng,et al."Autoantibody levels as biomarkers of disease activity in management of myasthenia gravis".EUROPEAN JOURNAL OF NEUROLOGY 30..4(2023):1160-1161